Related Experiment Video
Updated: Aug 19, 2026

Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain
Published on: July 24, 2016
Update on perinatal HIV transmission
M G Fowler1, R J Simonds, A Roongpisuthipong
1Pediatric and Adolescent Studies Section, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. mgf1@cdc.gov
Abstract:
Over the past decade, much progress has been made in understanding the risk factors and timing of perinatal HIV transmission. Even more impressive have been the successful clinical trials with antiretrovirals, such as ZDV, ZDV-3TC, and nevirapine, that demonstrated significant reductions in the risk for infant infection. Within the United States and Europe, these trial results have led to rapid implementation and dramatic decreases in new perinatal HIV cases since 1994. An immediate challenge is to rapidly translate the short-course antiretroviral trial results with ZDV and nevirapine into public health policy and practice in resource-poor settings, where almost 600,000 neonates continue to become infected by mother-infant HIV transmission each year. Physicians must also test strategies to further decrease the risk for infant HIV infection during the breast-feeding period.
More Related Videos
08:12Isolation of Leukocytes from Human Breast Milk for Use in an Antibody-dependent Cellular Phagocytosis Assay of HIV Targets
Published on: September 6, 2019
05:22Ex vivo Culture of Human Placental Explants for the Study of Viral Transmission Across the Maternal-Fetal Interface
Published on: December 30, 2025
Related Concept Videos
Retrovirus Life Cycles
Sexually Transmitted Infections
Development of the Oral Microbiota
Transmission of Pathogens
Cryptococcal Meningitis
Inhibitors of Virion Maturation and Assembly